Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EOLS compared with VYNE: revenue, margins and what each company keeps, and the suppliers and customers both name
EOLS
Evolus, Inc.
Change
Mkt cap
Revenue
Revenue
VYNE
VYNE Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
EOLS
Evolus, Inc.
vs
VYNE
VYNE Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
EOLS
with
VYNE
Uncorrelated: r 0.13 · 501D.
No shared co-movers.
EOLS, solid
VYNE, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
EOLS
Evolus, Inc.
Change
7.17
· pre 7.17
· delayed
Mkt cap
$472.9M
Revenue
$84M
Q2 FY26
Revenue
$297M
FY25
VYNE
VYNE Therapeutics Inc.
Change
17.86
· pre 17.86
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 2 '26
delayed
EOLS
Evolus, Inc.
vs
VYNE
VYNE Therapeutics Inc.
7.17
pre 7.17
delayed
Price
17.86
pre 17.86
delayed
$472.9M
Mkt cap
—
Q2 FY26
$84M
Revenue
—
FY25
$297M
Revenue
—
Change
Change
EOLS
7.17
vs
VYNE
17.86
Pre-market
Nov 2 '26
delayed